+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • ID: 5118130
  • Report
  • June 2020
  • Region: Global
  • 104 pages
  • IMARC Group

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 10x Genomics
  • BGI Group
  • F. Hoffmann-La Roche AG
  • Genewiz
  • Macrogen
  • PerkinElmer
The global next-generation sequencing (NGS) market is currently witnessing robust growth. Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the market further. Looking forward, the publisher expects the market to register a CAGR of around 17% during 2020-2025.

Breakup by Sequencing Type:
  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others
Breakup by Product Type:
  • Instruments
  • Reagents and Consumables
  • Software and Services
Breakup by Technology:
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others
Breakup by Application:
  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others
Breakup by End-User:
  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in this Report:
  • How has the global next-generation sequencing market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the sequencing type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global next-generation sequencing market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 10x Genomics
  • BGI Group
  • F. Hoffmann-La Roche AG
  • Genewiz
  • Macrogen
  • PerkinElmer
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Sequencing Type
6.1 Whole Genome Sequencing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Targeted Resequencing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Whole Exome Sequencing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 RNA Sequencing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 CHIP Sequencing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 De Novo Sequencing
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Methyl Sequencing
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast

7 Market Breakup by Product Type
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Reagents and Consumables
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Software and Services
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Technology
8.1 Sequencing by Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ion Semiconductor Sequencing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Single-Molecule Real-Time Sequencing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nanopore Sequencing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Application
9.1 Drug Discovery and Personalized Medicine
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Genetic Screening
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diagnostics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Agriculture and Animal Research
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by End-User
10.1 Academic Institutes & Research Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals & Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical & Biotechnology Companies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast

11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 10x Genomics
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 BGI Group
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Eurofins Scientific
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 F. Hoffmann-La Roche AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Illumina Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Genewiz
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Macrogen Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Oxford Nanopore Technologies
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Pacific Biosciences
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Perkinelmer Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Thermo Fisher Scientific Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
16.3.14 Qiagen N.V.
16.3.14.1 Company Overview
16.3.14.2 Product Portfolio
16.3.14.3 Financials
16.3.14.4 SWOT Analysis
16.3.15 Genapsys Inc.
16.3.15.1 Company Overview
16.3.15.2 Product Portfolio
Note: Product cover images may vary from those shown
  • Agilent Technologies
  • Becton Dickinson and Company
  • 10x Genomics
  • BGI Group
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Genewiz
  • Macrogen
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PerkinElmer
  • Thermo Fisher Scientific
  • Qiagen N.V.
  • GenapSys Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll